Patients with @ micturitions/@h and @ urgency episode/@h or @ urgency incontinence episode/@h were randomised to once-daily placebo , mirabegron @mg or tolterodine @mg ( as an active comparator , without testing for non-inferiority of efficacy and safety ) for @ weeks .